https://www.selleckchem.com/pr....oducts/ide397-gsk-43
The deposition of amyloid-beta (Aβ) through the cleavage of amyloid-beta precursor protein (APP) is a biomarker of Alzheimer's disease (AD). This study used QIAGEN Ingenuity Pathway Analysis (IPA) to conduct meta-analysis on the molecular mechanisms by which methamphetamine (METH) impacts AD through modulating the expression of APP. All the molecules affected by METH and APP were collected from the QIAGEN Knowledge Base (QK; 78 overlapping molecules were identified. Upon simulation of METH exposure using the "Molecule Activ
Like
Comment
Share
